Informa

Bridging Science and Health in
Biopharma Industry

19th-20th August 2025.

Hyderabad.

BIOPHARMA CONCLAVE 2025

The 7^th Edition of Biopharma Conclave is scheduled for 19th-20th August 2025 in Hyderabad and will be a grand platform for discussing the trends, challenges, solutions, and innovation in the industry. For the first time, this preview comes in two extensive product-based tracks -: Biosimilars & Biologics, And Cell & Gene.

What’s Happening this Year

30+ hours of engaging content across 2 days

30+ Speakers

200+ Biopharma industry professionals under one roof

6 hours of Networking session

International speakers from the US, Europe, and APAC

Technology Showcase

2 conference tracks – Biosimilars & Biologics and Cell & Gene Therapy

Regulatory update panel by Key Regulatory bodies

Key Focus Areas

Biosimilars & Biologics

The track is extensively spread over two days covering key aspects of Biosimilars: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.

Cell and Gene Therapy

The track will emphasize on CGT: Innovation, Technology, Clinical Trials, Regulatory, Supply Chain, and Commercialization.

We have a proven track record of success

50+

Speakers

25+

Exhibitors

4+

Focused tracks

300

Attendees

Our Speakers

Parthasarathy Sampathkumar

Head- Biocon Group Centre of Excellence

Biocon Group

Ranjan Chakrabarti

Advisor-NIPER-Mohali & Executive Committee Member-Federation of Asian Biotech Association (FABA)

Dinesh Kundu

Director & Co-Founder

East Ocyon Bio

Abhishek Mathur

Chief Scientific Officer

Enzene Biosciences

Prof. Samir Kulkarni

Head - Department of Biological Sciences and Biotechnology

Institute of Chemical Technology

Mannan Khambati

Vice President -Biotech Manufacturing

Bharat Serums & Vaccines

Mayank Garg

General Manager- MSAT

Biocon Biologics

Sweety Mathew

Director - Regulatory Affairs

Novo Nordisk

Abir Banerjee

Vice President- R&D

Bharat Serums & Vaccines

Sayan Basu

Network Director of Research

L V Prasad Eye Institute

Dhananjay Patankar

Biopharma Expert

Akhil Kumar

Head Clinical Development

Aurigene Oncology

Priyadarshini Chatterjee

Head R&D

Aurigene Oncology

Shubhadeep Sinha

SVP- Development

Hetero

Ramanathan Kalyanasundaram

Head of Manufacturing & Technical Operations- Biosimilars

Reliance Life Sciences

Dr. Arkasubhra Ghosh

Director, Grow Laboratory

Narayana Nethralaya Foundation

Dr. Nitin Damle

Executive Vice-President and Chief Innovation Officer

Sun Pharma Advanced Research Company, Ltd. (SPARC)

Dr. Prasun Guha

Vice President & Head of Regulatory Affairs - Biologics

Dr. Reddys Laboratories

Testimonials

What People Say?

Interactions have been very good, exchange of information in terms of biosimilars, vaccines or even the cell & gene therapy is very new in the market. There is a lot of learning from both ends. The footfall for this event in the last two days have been phenomenal and more than expected.

Vishal Jaiman

Director – Business Development (India), Marken

Biopharma Conclave was very good, I think there are a lot more players in the market with lot more presenting this year.It’s an interesting mix of all the topics they have put together as the Biopharma industry is moving further into commercialization. This is a good platform for a lot of us to connect and present our views.

Gopal Rao

GM- Global BD and Licensing, Lupin Limited (Biotech Division)

So far it has been a wonderful experience and I was able to interact as well as meet many key personalities from India and abroad. We have expertise industry research in Biosimilars, Biologics, Vaccines and Gene therapy hence it has been a wonderful experience to learn a lot of advance techniques and development happening in this space.

Ramgopal Rao

Academic Manger, Biocon Academy

My experience at the Biopharma Conclave was great. It was good to hear from so many experts in the field of biopharma. The quality of the speakers is top notch, and it was great to hear from regulators and industry experts.

Dr. Sarah McMullen

Country Director, US FDA

This is the first day but there were so many interesting topics withvery interesting speakers. It was a networking event and informative session with lots of people.

Yaron R. Silberberg

PHD. Chief Scientist, Cellist Solution Center

I was very glad to know that there were ample safety protocols followed whilst hosting a show post Covid. There was also a self-declaration form which each of the participants had to sign. There was a thermal screening at the entrance. In terms of the discussion the dignities who came there were all very well recognized and knowledgeable. It was great to learn from each other and a great platform as well.

Divya Bijlwan

Senior Vice President- Business development, Aurobindo Pharma Ltd.

It’s a very nice gathering and we have people come here from various streams that is Vaccines, Biosimilars and Gene therapy.

Alston Fernandes

Head Technical, JNC Corporation

Bridging Science and Health in Biopharma Industry